An official website of the United States government.

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Food Safety Publications

The Food Safety Publications tracks research that is published across national and international peer-reviewed journals. Recent articles are available ahead of print and searchable by Journal, Article Title, and Category. The research publications are tracked across six categories: Bacterial Pathogens, Chemical Contaminants, Natural Toxins, Parasites, Produce Safety, and Viruses. Articles produced by USDA Grant Funding Agencies and FDA Grant Funding Agencies are also tracked.

Displaying 1 - 25 of 173

  1. Genomic Characterisation of CC398 MRSA Causing Severe Disease in Australia

    • Wed, 03/23/2022 - 06:00
    • International Journal of Antimicrobial Agents
    • Complex (CC) 398 livestock-associated methicillin-resistant Staphylococcus aureus (LA-MRSA) has been reported worldwide in a variety of food-animal species.

      • Bacterial pathogens
      • Staphylococcus aureus
  2. MRSA Surveillance Programmes Worldwide: Moving towards a harmonised international approach

    • Thu, 01/27/2022 - 12:00
    • International Journal of Antimicrobial Agents
    • Multinational surveillance programmes for methicillin-resistant Staphylococcus aureus (MRSA) are dependent on national structures for data collection. This study aimed to capture the diversity of national MRSA surveillance programmes and propose a framework for harmonisation of MRSA surveillance.

      • Bacterial pathogens
      • Staphylococcus aureus
  3. Genotyping of methicillin-resistant Staphylococcus aureus isolates causing invasive infections using spa typing and their correlation with antibiotic susceptibility

    • Mon, 01/17/2022 - 06:00
    • International Journal of Antimicrobial Agents
    • The antibiotic susceptibility patterns were correlated with particular spa types, and this correlation would help physicians select appropriate antibiotics for treatment of invasive MRSA infections. The aim of this research was to investigate invasive methicillin-resistant Staphylococcus aureus (MRSA) through delineatingthe molecular typing results and correlating them with antibiotic susceptibility.

      • Bacterial pathogens
      • Staphylococcus aureus
  4. A potent HDAC inhibitor blocks Toxoplasma gondii tachyzoite growth and profoundly disrupts parasite gene expression

    • Sun, 01/16/2022 - 06:00
    • International Journal of Antimicrobial Agents
    • Toxoplasmosis is a major health issue worldwide especially for immune-deficient individuals and the offspring of newly infected mothers. It is caused by a unicellular intracellular parasite called Toxoplasma gondii. Although the drugs commonly used to treat toxoplasmosis are efficient, they present serious side effects and adverse events are common. Therefore, there is a need for the discovery of new compounds with potent anti-T. gondii activity.

      • Parasites
      • Toxoplasma gondii
  5. Change in Antimicrobial Use During COVID-19 Pandemic in South Carolina Hospitals: A Multicenter Observational Cohort Study

    • Wed, 01/12/2022 - 22:17
    • International Journal of Antimicrobial Agents
      • Viruses
      • COVID-19
  6. Ceftriaxone versus antistaphylococcal antibiotics for definitive treatment of methicillin-susceptible Staphylococcus aureus infections: a systematic review and meta-analysis

    • Wed, 01/12/2022 - 22:17
    • International Journal of Antimicrobial Agents
      • Bacterial pathogens
      • Staphylococcus aureus
  7. Evaluation of early antibiotic use in patients with non‐severe COVID‐19 without bacterial infection

    • Wed, 01/12/2022 - 22:17
    • International Journal of Antimicrobial Agents
      • Viruses
      • COVID-19
  8. Effects of simeprevir on the replication of SARS-CoV-2 in vitro and in transgenic hACE2 mice

    • Wed, 01/12/2022 - 22:17
    • International Journal of Antimicrobial Agents
      • Viruses
      • COVID-19
  9. High dose ivermectin for the early treatment of COVID-19 (COVER study): a randomised, double-blind, multicentre, phase II, dose-finding, proof of concept clinical trial

    • Wed, 01/12/2022 - 22:17
    • International Journal of Antimicrobial Agents
      • Viruses
      • COVID-19
  10. Colistin- and tigecycline-resistant CTX-M-14-producing Salmonella enterica serovar Kentucky ST198 from retail chicken meat, China

    • Sun, 12/19/2021 - 06:06
    • International Journal of Antimicrobial Agents
    • Author(s): Jing Wang, Yue Jiang, Ruo-Yun Ji, Zhen-Yu Wang, Meng-Jun Lu, Han Wu, Cai-Yue Mei, Qiu-Chun Li, Xinan Jiao Colistin and tigecycline are regarded as the last-resort antibiotics for the treatment of serious clinical infections caused by enxtensively drug-resistant Gram-negative organisms, particularly carbapenemase-producing Enterobacteriaceae and Acinetobacter isolates, but the emergence and spread of plasmid-mediated colistin (mcr) or tigecycline [tet(X) and tmexCD1-toprJ1] resistan

      • Bacterial pathogens
      • Salmonella
  11. Corrigendum to “Anionic phospholipid expression as a molecular target in Listeria monocytogenes and Escherichia coli” [International Journal of Antimicrobial Agents, Volume 56, Issue 6, December 2020, 106183]

    • Sun, 09/12/2021 - 06:06
    • International Journal of Antimicrobial Agents
    • Author(s): Patrick McKernan, Benjamin Cassidy, Alexis Woodward, James Battiste, Douglas Drevets, Roger Harrison

      • Listeria monocytogenes
      • Bacterial pathogens
  12. Circulation of multidrug-resistant Shigella sonnei and Shigella flexneri among men who have sex with men in Barcelona, Spain, 2015-2019.

    • Thu, 06/24/2021 - 06:08
    • International Journal of Antimicrobial Agents
    • Author(s): Albert Moreno-Mingorance, Paula Espinal, Virginia Rodriguez, Lidia Goterris, Anna Fàbrega, Judit Serra-Pladevall, M. Jesús Barberà, M. Alberny, Héctor Martín-González, Thais Cornejo-Sánchez, Mayuli Armas, Alba Mir-Cros, Alex Raventós, Belén Viñado, T. Pumarola, M.N. Larrosa, Juan José González-López

      • Shigella
      • Bacterial pathogens
  13. Molecular genetic characteristic of mcr-9-harbouring Salmonella enterica Serotype Typhimurium isolated from raw milk: mcr-9 in Salmonella enterica Serotype Typhimurium from raw milk

    • Thu, 04/01/2021 - 06:18
    • International Journal of Antimicrobial Agents
    • Author(s): Xiaoming Wang, Zhuoren Ling, Naiyan Sun, Yongshi Liu, Jinhu Huang, Liping Wang

      • Bacterial pathogens
      • Salmonella
  14. Anionic Phospholipid Expression as a Molecular Target in Listeria monocytogenes and Escherichia coli

    • Sun, 10/11/2020 - 06:16
    • International Journal of Antimicrobial Agents
    • Author(s): Patrick McKernan, Benjamin Cassidy, Alexis Woodward, James Battiste, Douglas Drevets, Roger Harrison

      • Listeria monocytogenes
      • Bacterial pathogens
  15. Adaptive laboratory evolution of Vibrio cholerae to doxycycline associated with spontaneous mutation

    • Sun, 08/30/2020 - 06:14
    • International Journal of Antimicrobial Agents
    • Author(s): Lekshmi Narendrakumar, Sivakumar Krishnankutty Chandrika, Sabu Thomas

      • Bacterial pathogens
      • Vibrio
  16. Recommendations for use of a hydroxychloroquine loading dose in patients with COVID-19

    • Mon, 08/24/2020 - 18:04
    • International Journal of Antimicrobial Agents
    • Author(s): Emre Kara, Kutay Demirkan, Serhat Unal

      • COVID-19
  17. Lactoferrin as potential preventative and adjunct treatment for COVID-19

    • Mon, 08/24/2020 - 18:04
    • International Journal of Antimicrobial Agents
    • Author(s): Raymond Chang, Tzi Bun Ng, Wei-Zen Sun

      • COVID-19
  18. Combating devastating COVID-19 by drug repurposing

    • Mon, 08/24/2020 - 18:04
    • International Journal of Antimicrobial Agents
    • Author(s): Ashish Yashwantrao Pawar

      • COVID-19
  19. COVID-19 treatment: close to a cure? A rapid review of pharmacotherapies for the novel coronavirus (SARS-CoV-2)

    • Mon, 08/24/2020 - 18:04
    • International Journal of Antimicrobial Agents
    • Author(s): Yang Song, Min Zhang, Ling Yin, Kunkun Wang, Yiyi Zhou, Mi Zhou, Yun Lu

      • COVID-19
  20. Macrolides and viral infections: focus on azithromycin in COVID-19 pathology

    • Mon, 08/24/2020 - 18:04
    • International Journal of Antimicrobial Agents
    • Author(s): Arianna Pani, Marinella Lauriola, Alessandra Romandini, Francesco Scaglione

      • COVID-19
  21. Corticosteroid therapy for patients with COVID-19 pneumonia: a before–after study

    • Mon, 08/24/2020 - 18:04
    • International Journal of Antimicrobial Agents
    • Author(s): Firouzé Bani-Sadr, Maxime Hentzien, Madeline Pascard, Yohan N'Guyen, Amélie Servettaz, Laurent Andreoletti, Lukshe Kanagaratnam, Damien Jolly

      • COVID-19
  22. A review on possible modes of action of chloroquine/hydroxychloroquine: repurposing against SAR-CoV-2 (COVID-19) pandemic

    • Mon, 08/24/2020 - 18:04
    • International Journal of Antimicrobial Agents
    • Author(s): Satyajit Tripathy, Barsha Dassarma, Somenath Roy, Hlupheka Chabalala, Motlalepula Gilbert Matsabisa

      • COVID-19
  23. Extra-respiratory manifestations of COVID-19

    • Mon, 08/24/2020 - 18:04
    • International Journal of Antimicrobial Agents
    • Author(s): Chih-Cheng Lai, Wen-Chien Ko, Ping-Ing Lee, Shio-Shin Jean, Po-Ren Hsueh

      • COVID-19
  24. Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal

    • Mon, 08/24/2020 - 18:04
    • International Journal of Antimicrobial Agents
    • Author(s): Jacques Fantini, Henri Chahinian, Nouara Yahi

      • COVID-19
  25. Computational screening of antagonists against the SARS-CoV-2 (COVID-19) coronavirus by molecular docking

    • Mon, 08/24/2020 - 18:04
    • International Journal of Antimicrobial Agents
    • Author(s): Ran Yu, Liang Chen, Rong Lan, Rong Shen, Peng Li

      • COVID-19